{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:01:36Z","timestamp":1771027296579,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HR21C0198"],"award-info":[{"award-number":["HR21C0198"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1A2C1095874"],"award-info":[{"award-number":["2021R1A2C1095874"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07524-w","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:55:47Z","timestamp":1764766547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated network propagation identifies prognostic metabolic signatures in acute myeloid leukemia"],"prefix":"10.1186","volume":"24","author":[{"given":"Jong Keon","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-6832","authenticated-orcid":false,"given":"Hyery","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3201-5728","authenticated-orcid":false,"given":"Sang-Hyun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"7524_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1101\/gad.349368.122","volume":"36","author":"JP Bewersdorf","year":"2022","unstructured":"Bewersdorf JP, Abdel-Wahab O. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic. Genes Dev. 2022;36:259\u201377.","journal-title":"Genes Dev"},{"key":"7524_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","volume":"2016","author":"CD DiNardo","year":"2016","unstructured":"DiNardo CD, Cortes JE. Mutations in AML: prognostic and therapeutic implications. Hematol Am Soc Hematol Educ Program. 2016;2016:348\u201355.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"7524_CR3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/cncr.33477","volume":"127","author":"HM Kantarjian","year":"2021","unstructured":"Kantarjian HM, Kadia TM, DiNardo CD, Welch MA, Ravandi F. Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach. Cancer. 2021;127:1186\u2013207.","journal-title":"Cancer"},{"key":"7524_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.12.004","volume":"110","author":"G Tamamyan","year":"2017","unstructured":"Tamamyan G, Kadia T, Ravandi F, Borthakur G, Cortes J, Jabbour E, Daver N, Ohanian M, Kantarjian H, Konopleva M. Frontline treatment of acute myeloid leukemia in adults. Crit Rev Oncol Hematol. 2017;110:20\u201334.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7524_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"7524_CR6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"7524_CR7","doi-asserted-by":"crossref","unstructured":"Song JK, Lee DH, Kim H, Hwang SH. Literature-Guided 6-Gene signature for the stratification of High-Risk acute myeloid leukemia. Cancer Res Treat. 2025.","DOI":"10.4143\/crt.2024.1114"},{"key":"7524_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nbt.1522","volume":"27","author":"IW Taylor","year":"2009","unstructured":"Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol. 2009;27:199\u2013204.","journal-title":"Nat Biotechnol"},{"key":"7524_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.semcancer.2012.02.011","volume":"22","author":"E Raspe","year":"2012","unstructured":"Raspe E, Decraene C, Berx G. Gene expression profiling to dissect the complexity of cancer biology: pitfalls and promise. Semin Cancer Biol. 2012;22:250\u201360.","journal-title":"Semin Cancer Biol"},{"key":"7524_CR10","doi-asserted-by":"publisher","first-page":"vbae099","DOI":"10.1093\/bioadv\/vbae099","volume":"4","author":"M Zitnik","year":"2024","unstructured":"Zitnik M, Li MM, Wells A, Glass K, Morselli Gysi D, Krishnan A, Murali TM, Radivojac P, Roy S, Baudot A, et al. Current and future directions in network biology. Bioinform Adv. 2024;4:vbae099.","journal-title":"Bioinform Adv"},{"key":"7524_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/msb4100180","volume":"3","author":"HY Chuang","year":"2007","unstructured":"Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007;3:140.","journal-title":"Mol Syst Biol"},{"key":"7524_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmoldx.2024.06.008","volume":"26","author":"US Shanthamallu","year":"2024","unstructured":"Shanthamallu US, Kilpatrick C, Jones A, Rubin J, Saleh A, Barabasi AL, Akmaev VR, Ghiassian SD. A Network-Based framework to discover Treatment-Response-Predicting biomarkers for complex diseases. J Mol Diagn. 2024;26:917\u201330.","journal-title":"J Mol Diagn"},{"key":"7524_CR13","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","volume":"13","author":"J Kong","year":"2022","unstructured":"Kong J, Ha D, Lee J, Kim I, Park M, Im SH, Shin K, Kim S. Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun. 2022;13:3703.","journal-title":"Nat Commun"},{"key":"7524_CR14","unstructured":"TCGA\u2013LAML. Acute Myeloid Leukemia (RNA-seq and clinical data). 2013."},{"key":"7524_CR15","unstructured":"BeatAML 1. 0 Cohort (BeatAML Master Trial): RNA-seq and clinical data. 2018."},{"key":"7524_CR16","unstructured":"TARGET\u2013AML. Therapeutically Applicable Research to Generate Effective Treatments (RNA-seq and clinical data). 2018."},{"key":"7524_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138.","journal-title":"Nat Biotechnol"},{"key":"7524_CR18","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"7524_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"7524_CR20","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J. G:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47:W191\u20138.","journal-title":"Nucleic Acids Res"},{"key":"7524_CR21","doi-asserted-by":"publisher","first-page":"574939","DOI":"10.3389\/fonc.2020.574939","volume":"10","author":"R Zhu","year":"2020","unstructured":"Zhu R, Tao H, Lin W, Tang L, Hu Y. Identification of an Immune-Related gene signature based on Immunogenomic landscape analysis to predict the prognosis of adult acute myeloid leukemia patients. Front Oncol. 2020;10:574939.","journal-title":"Front Oncol"},{"key":"7524_CR22","doi-asserted-by":"crossref","unstructured":"Zhai Y, Shen H, Wei H. A comprehensive Metabolism-Related gene signature predicts the survival of patients with acute myeloid leukemia. Genes (Basel). 2023;15.","DOI":"10.3390\/genes15010063"},{"key":"7524_CR23","doi-asserted-by":"crossref","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, Dickins B, Altmann H, Kramer M, Knaus HA et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022;132.","DOI":"10.1172\/JCI159579"},{"key":"7524_CR24","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1182\/bloodadvances.2023010155","volume":"7","author":"L Vasseur","year":"2023","unstructured":"Vasseur L, Fenwarth L, Lambert J, de Botton S, Figeac M, Villenet C, Heiblig M, Dumas P-Y, R\u00e9cher C, Berthon C. LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood Adv. 2023;7:4024\u201334.","journal-title":"Blood Adv"},{"key":"7524_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, Arruda A, Popescu A, Gupta V, Schimmer AD, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433\u20137.","journal-title":"Nature"},{"key":"7524_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1137\/040608635","volume":"30","author":"S Van Dongen","year":"2008","unstructured":"Van Dongen S. Graph clustering via a discrete uncoupling process. SIAM J Matrix Anal Appl. 2008;30:121\u201341.","journal-title":"SIAM J Matrix Anal Appl"},{"key":"7524_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1471-2105-7-488","volume":"7","author":"S Brohee","year":"2006","unstructured":"Brohee S, Van Helden J. Evaluation of clustering algorithms for protein-protein interaction networks. BMC Bioinformatics. 2006;7:488.","journal-title":"BMC Bioinformatics"},{"key":"7524_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/15578100251370570","volume":"29","author":"K Karagoz","year":"2025","unstructured":"Karagoz K, Roukens MG, Comijn L, Celik A, Brady LK, Higgs BW, Si H. Integrative genomic and immune profiling to identify and characterize High-Risk subgroups in acute myeloid leukemia: development of a 20-Gene predictive signature and its clinical implications. OMICS. 2025;29:458\u201372.","journal-title":"OMICS"},{"key":"7524_CR29","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1038\/s41598-024-59464-y","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Wang H, Ding Y, Jiao X, Zhu J, Zhai Z. NET-related gene signature for predicting AML prognosis. Sci Rep. 2024;14:9115.","journal-title":"Sci Rep"},{"key":"7524_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","volume":"18","author":"CJ Pirozzi","year":"2021","unstructured":"Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy. Nat Rev Clin Oncol. 2021;18:645\u201361.","journal-title":"Nat Rev Clin Oncol"},{"key":"7524_CR31","doi-asserted-by":"publisher","first-page":"1424365","DOI":"10.3389\/fgene.2024.1424365","volume":"15","author":"N Ren","year":"2024","unstructured":"Ren N, Wang J, Li R, Yin C, Li M, Wang C. Prognostic implications of metabolism-related genes in acute myeloid leukemia. Front Genet. 2024;15:1424365.","journal-title":"Front Genet"},{"key":"7524_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010;17:225\u201334.","journal-title":"Cancer Cell"},{"key":"7524_CR33","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, D\u2019Alessandro A, Culp-Hill R, Riemondy KA, Gillen AE, et al. Venetoclax with Azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24:1859\u201366.","journal-title":"Nat Med"},{"key":"7524_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood. 2023;141:1119\u201335.","journal-title":"Blood"},{"key":"7524_CR35","doi-asserted-by":"publisher","first-page":"153303382211406","DOI":"10.1177\/15330338221140655","volume":"21","author":"T Hu","year":"2022","unstructured":"Hu T, Chen X, Lu S, Zeng H, Guo L, Han Y. Biological role and mechanism of lipid metabolism reprogramming related gene ECHS1 in cancer. Technol Cancer Res Treat. 2022;21:15330338221140655.","journal-title":"Technol Cancer Res Treat"},{"key":"7524_CR36","doi-asserted-by":"publisher","first-page":"eabk1023","DOI":"10.1126\/sciadv.abk1023","volume":"7","author":"H Ding","year":"2021","unstructured":"Ding H, Chen Z, Wu K, Huang SM, Wu WL, LeBoeuf SE, Pillai RG, Rabinowitz JD, Papagiannakopoulos T. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD Inhibition. Sci Adv. 2021;7:eabk1023.","journal-title":"Sci Adv"},{"key":"7524_CR37","doi-asserted-by":"crossref","unstructured":"Zhang R, Jin W, Wang K. Glycolysis-Driven prognostic model for acute myeloid leukemia: insights into the immune landscape and drug sensitivity. Biomedicines. 2025;13.","DOI":"10.3390\/biomedicines13040834"},{"key":"7524_CR38","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"CD DiNardo","year":"2018","unstructured":"DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Swords R, Collins RH, Mannis GN, Pollyea DA, et al. Durable remissions with Ivosidenib in IDH1-Mutated relapsed or refractory AML. N Engl J Med. 2018;378:2386\u201398.","journal-title":"N Engl J Med"},{"key":"7524_CR39","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"P Montesinos","year":"2022","unstructured":"Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh SP, et al. Ivosidenib and Azacitidine in IDH1-Mutated acute myeloid leukemia. N Engl J Med. 2022;386:1519\u201331.","journal-title":"N Engl J Med"},{"key":"7524_CR40","doi-asserted-by":"publisher","first-page":"1513938","DOI":"10.3389\/fgene.2024.1513938","volume":"15","author":"CY Lu","year":"2024","unstructured":"Lu CY, Liu Z, Arif M, Alam T, Qiu WR. Integration of gene expression and DNA methylation data using MLA-GNN for liver cancer biomarker mining. Front Genet. 2024;15:1513938.","journal-title":"Front Genet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07524-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:02:07Z","timestamp":1771023727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7524"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07524-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used anonymous, secondary data; hence, it was exempted from review by the Institutional Review Board of the Asan Medical Center, Korea. The requirement for written informed consent was waived for the same reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}